Beyond conventional immune-checkpoint inhibition—novel immunotherapies for renal cell carcinoma
The management of advanced-stage renal cell carcinoma (RCC) has been transformed by
the development of immune-checkpoint inhibitors (ICIs). Nonetheless, most patients do not …
the development of immune-checkpoint inhibitors (ICIs). Nonetheless, most patients do not …
[HTML][HTML] Beyond conventional immune checkpoint inhibition: renal cell carcinoma at the forefront of solid tumor immunology
The management of advanced renal cell carcinoma (RCC) has been transformed by the
development of immune checkpoint inhibitors (ICIs), but still most RCC patients do not …
development of immune checkpoint inhibitors (ICIs), but still most RCC patients do not …
Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8+ T cell-associated …
H Gao, H Sun, A He, H Liu, Z Zhang, D Li… - European Journal of …, 2024 - Springer
Background Kidney cancer is an immunogenic solid tumor, characterized by high tumor
burden and infiltration of CD8+ T cells. Although immunotherapy targeting the PD1/CTLA-4 …
burden and infiltration of CD8+ T cells. Although immunotherapy targeting the PD1/CTLA-4 …